Showing results (151-160 of 584) with videos related to

Sort By:
Pageof 59
The Lancet. Oncology|November 18, 2008
Preserving function and quality of life after thyroid and parathyroid surgeryJoel T Adler, Rebecca S Sippel, Sarah Schaefer, et al.
American Journal of Surgery|July 13, 2024
Normocalcemic primary hyperparathyroidism: From pathophysiology to clinical managementChristopher Wu, Andrea Gillis, Brenessa Lindeman, et al.
Molecular Cancer Therapeutics|June 16, 2005
ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cellsJamie J Van Gompel, Muthusamy Kunnimalaiyaan, Kyle Holen, et al.
The Journal of Surgical Research|April 30, 2013
Radioactive iodine scanning is not beneficial but its use persists for euthyroid patientsRajarajan Panneerselvan, David F Schneider, Rebecca S Sippel, et al.
Surgery|December 5, 2009
Tertiary hyperparathyroidism: is less than a subtotal resection ever appropriate? A study of long-term outcomesSusan C Pitt, Rajarajan Panneerselvan, Herbert Chen, et al.
American Journal of Surgery|March 16, 2010
Influence of morbid obesity on parathyroidectomy outcomes in primary hyperparathyroidismSusan C Pitt, Rajarajan Panneerselvan, Rebecca S Sippel, et al.
American Journal of Surgery|February 28, 2009
Surgery improves quality of life in patients with "mild" hyperparathyroidismJoel T Adler, Rebecca S Sippel, Sarah Schaefer, et al.
The Journal of Surgical Research|April 28, 2009
Inhibition of growth in medullary thyroid cancer cells with histone deacetylase inhibitors and lithium chlorideJoel T Adler, Daniel G Hottinger, Muthusamy Kunnimalaiyaan, et al.
The Oncologist|December 19, 2008
Carcinoid tumorsScott N Pinchot, Kyle Holen, Rebecca S Sippel, et al.
The Journal of Biological Chemistry|November 9, 2006
Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cellsMuthusamy Kunnimalaiyaan, Abram M Vaccaro, Mary A Ndiaye, et al.
Pageof 59